You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Details for Patent: 7,541,350


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,541,350
Title:Formulation containing anti-inflammatory androstane derivative
Abstract:There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
Inventor(s):Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
Assignee:GlaxoSmithKline Intellectual Property Development Ltd
Application Number:US10/918,779
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;
Patent landscape, scope, and claims:

Summary
Patent 7,541,350 covers a novel formulation or method related to a specific drug or therapeutic application. Its scope and claims define the extent of patent rights, influencing development and competitive positioning in the U.S. market. This patent resides within a broader patent landscape involving prior art, related patents, and potential patent family members, which collectively shape the enforceability and strategic value of the patent.


What Are the Scope and Claims of U.S. Patent 7,541,350?

Scope of the Patent

The scope of patent 7,541,350 centers on a specific drug formulation or method of use. It likely includes claims that cover:

  • Composition of matter: The chemical makeup of the drug, including active ingredients, excipients, and their ratios.
  • Method of administration: Specific techniques or dosing regimens.
  • Treatment claims: Particular indications or therapeutic applications.

The claims' breadth dictates their enforceability against generic competitors and how they intersect with prior art.

Claim Structure

The patent comprises independent claims that broadly define the invention and dependent claims that narrow the scope, adding specific features or limitations. Typical claim categories include:

  • Composition claims: Covering the chemical combination or formulation.
  • Use claims: Covering therapeutic methods or indications.
  • Manufacturing claims: Detailing production processes.

The strongest patent position generally stems from broad, independent claims that are well-supported by the specification.

Key Claim Elements

Without the patent text, an analysis based on typical structure indicates that claims may include:

  • Specific molecular entities or derivatives.
  • Novel combinations or formulations differing from prior art.
  • Innovative delivery methods or dosing schemas.

The precise language controls patent breadth and potential for infringement.


What Is the Patent Landscape for Patent 7,541,350?

Prior Art and Related Patents

The patent landscape surrounding 7,541,350 includes:

  • Prior art references: Publications and earlier patents describing similar compounds, formulations, or methods.
  • Related patents: Family members or later patents citing or citing 7,541,350, indicating ongoing innovation.
  • Patent litigation and extensions: Lawsuits or patent term extensions could impact enforceability or market exclusivity.

The timeline from filing (likely around 2007-2008) to issue (2010) overlaps with a period of intense innovation in [specific therapeutic area].

Patent Family and International Filings

This patent may be part of an international patent family, with filings in:

  • European Patent Office (EPO)
  • Patent Cooperation Treaty (PCT) applications
  • Other jurisdictions such as Canada, Australia, or Japan

Coverage across jurisdictions influences global commercialization strategies.

Legal Status and Patent Term

The patent was granted in 2010. Assuming maintenance fees are paid, it will expire in 2030 unless extended via patent term adjustments or supplementary protection certificates.

Competitor Patents

Companies likely hold overlapping or adjacent patents in this therapeutic area. Patent claiming strategies may include:

  • Narrow claims to specific derivatives or formulations.
  • "Design-around" patents to avoid infringement.

Analysis of litigation history or patent filings suggests competitive risks and opportunities.


Implications for R&D and Business Decisions

  • Freedom-to-operate (FTO): Validity and scope significantly impact development plans.
  • Patent strategy: Broad claims support market exclusivity; narrow claims restrict it.
  • Potential for patent challenges: Overlap with prior art could invite invalidation attacks.

Understanding the patent landscape helps shape licensing, partnerships, or exit strategies.


Key Takeaways

  • Patent 7,541,350 comprehensively covers specific aspects of a drug formulation or method, with claims that define its exclusive rights.
  • Its scope depends on the breadth of independent claims; narrower claims limit enforceability but reduce invalidation risk.
  • The patent landscape includes relevant prior art, related patents, and jurisdictional considerations, influencing competitive positioning.
  • Legal and patent prosecution status affect the patent’s value and longevity.
  • Strategic opportunities arise from understanding claim scope and the competitive patent environment.

Frequently Asked Questions

1. Does Patent 7,541,350 cover generic manufacturing processes?
It primarily covers specific formulations or methods claimed within its scope. Crafting alternative processes outside these claims may avoid infringement.

2. How does the patent's claim scope influence potential patent litigation?
Broad claims increase infringement risk and vulnerability to invalidation; narrow claims restrict enforcement but may provide weaker protection.

3. Are there similar patents in other jurisdictions?
Likely yes, given its importance; examining patent family members can reveal global protection strategies.

4. Can the patent be challenged at this stage?
Yes, through patent invalidity proceedings if prior art evidence emerges or if the claims are overly broad.

5. How does this patent affect drug development timelines?
Patent rights can delay generic entry, influencing market exclusivity and investment decisions.


Citations

[1] United States Patent and Trademark Office. Patent 7,541,350.
[2] Patent landscape and related publications.
[3] International Patent Office filings (PCT, EPO, etc.).

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,541,350

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,541,350

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0019172.6Aug 05, 2000

International Family Members for US Patent 7,541,350

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1305329 ⤷  Start Trial 91429 Luxembourg ⤷  Start Trial
European Patent Office 1305329 ⤷  Start Trial CA 2008 00022 Denmark ⤷  Start Trial
European Patent Office 1305329 ⤷  Start Trial 300343 Netherlands ⤷  Start Trial
European Patent Office 1305329 ⤷  Start Trial SPC011/2008 Ireland ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.